Litcius/Paper detail

Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries

Zobair M. Younossi, James M. Paik, Jeffrey V. Lazarus, Patrizia Burra, Yuichiro Eguchi, Frank Tacke, Javier Crespo, Cristiane Alves Villela‐Nogueira, Paul Brennan, Hussain Abdulrahman Al‐Omar, Manuel Romero‐Gómez, Cyrielle Caussy, Mário Guimarães Pessôa, Kenneth Cusi, Michael Roden, Hirokazu Takahashi, Amalia Gastaldelli, Jörn M. Schattenberg, Cláudia P. Oliveira, Takumi Kawaguchi, Yuko Eguchi, Jérôme Boursier, Faisal Abaalkhail, Jeremy Tomlinson, Alina M. Allen, Vincent Wai‐Sun Wong, Elisabetta Bugianesi, Philip N. Newsome, José Luís Calleja, Nicolai Brachowicz, Leire Agirre‐Garrido, Douglas Maya‐Miles, Habeeb Ibrahim Abdul Razack, Henry E. Mark, Ariana Nader, Sara Battistella, Jennifer Margier, Alessandra Risso, Maria Stepanova, Fatema Nader, Linda Henry, Laurent Castéra, Saleh A. Alqahtani

2025Clinical Gastroenterology and Hepatology10 citationsDOI

Topics & Concepts

MedicineEconomic impact analysisProductivityEnvironmental healthBurden of diseaseDisease burdenWork (physics)Quality of life (healthcare)Global healthIndirect costsEconomic growthMedical careEconomic costQuality-adjusted life yearAgricultural economicsCost–benefit analysisMedical costsDiseaseEnvironmental protectionBaseline (sea)Liver Disease Diagnosis and TreatmentDiet and metabolism studiesHepatitis C virus research
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries | Litcius